A kinetic and conformational study on the interaction of tetrahydropteridines with tyrosine hydroxylase

被引:20
作者
Almås, B
Toska, K
Teigen, K
Groehn, V
Pfleiderer, W
Martínez, A
Flatmark, T
Haavik, J
机构
[1] Univ Bergen, Dept Biochem & Mol Biol, N-5009 Bergen, Norway
[2] Univ Konstanz, Fak Chem, D-78434 Constance, Germany
关键词
D O I
10.1021/bi0011983
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetrahydropterins are obligatory cofactors for tyrosine hydroxylase (TH), the rate-limiting enzyme of catecholamine biosynthesis. A series of synthetic analogues of 6(R)-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) with different substituents in positions C2, N3, C4, N5, C6, C7, and N8 on the ring were used as active site probes for recombinant human TH. The enzyme tolerates rather bulky substituents at C6, as seen by the catalytic efficiency (V-max/K-m) and the couplings efficiency (mol of L-DOPA produced/mol of tetrahydropterin oxidized) of the cofactors. Substitutions at C2, C4, N5, and Ns abolish the cofactor activity of the pterin analogues. Molecular docking of BH4 into the crystal structure of the catalytic domain of ligand-free rat TH results in complexes in which the pteridine ring pi -stacks with Phe300 and the N3 and the amino group at C2 hydrogen bonds with Glu332. The pteridine ring also establishes interactions with Leu294 and Gln310. The distance between C4a in the pteridines and the active site iron was 4.2 +/- 0.5 Angstrom for the ensemble of docked conformers. Docking of BH4 analogues into TH also shows that the most bulky substituents at C6 can be well-accommodated within the large hydrophobic pocket surrounded by Ala297, Ser368, Tyr371, and Trp372, without altering the positioning of the ring. The pterin ring of 7-BH4 shows proper stacking with Phe300, but the distance between the C4a and the active site iron is 0.6 Angstrom longer than for bound BH4, a finding that may be related to the high degree of uncoupling observed for 7-BH4.
引用
收藏
页码:13676 / 13686
页数:11
相关论文
共 63 条
[31]   Crystal structure of tyrosine hydroxylase at 2.3 angstrom and its implications for inherited neurodegenerative diseases [J].
Goodwill, KE ;
Sabatier, C ;
Marks, C ;
Raag, R ;
Fitzpatrick, PF ;
Stevens, RC .
NATURE STRUCTURAL BIOLOGY, 1997, 4 (07) :578-585
[32]  
GROEHN V, 1996, THESIS U KONSTANZ GE
[33]   SOLUBLE TYROSINE-HYDROXYLASE (TYROSINE 3-MONOOXYGENASE) FROM BOVINE ADRENAL-MEDULLA - LARGE-SCALE PURIFICATION AND PHYSICOCHEMICAL PROPERTIES [J].
HAAVIK, J ;
ANDERSSON, KK ;
PETERSSON, L ;
FLATMARK, T .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 953 (02) :142-156
[34]   RECOMBINANT HUMAN TYROSINE-HYDROXYLASE ISOZYMES - RECONSTITUTION WITH IRON AND INHIBITORY EFFECT OF OTHER METAL-IONS [J].
HAAVIK, J ;
LEBOURDELLES, B ;
MARTINEZ, A ;
FLATMARK, T ;
MALLET, J .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 199 (02) :371-378
[35]   RAPID AND SENSITIVE ASSAY OF TYROSINE 3-MONOOXYGENASE ACTIVITY BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING THE NATIVE FLUORESCENCE OF DOPA [J].
HAAVIK, J ;
FLATMARK, T .
JOURNAL OF CHROMATOGRAPHY, 1980, 198 (04) :511-515
[36]  
Haavik J, 1997, J NEUROCHEM, V68, P328
[37]  
Heizmann G, 1995, PTERIDINES, V6, P153
[38]   A mechanism for hydroxylation by tyrosine hydroxylase based on partitioning of substituted phenylalanines [J].
Hillas, PJ ;
Fitzpatrick, PF .
BIOCHEMISTRY, 1996, 35 (22) :6969-6975
[39]   Pterin-dependent amino acid hydroxylases [J].
Kappock, TJ ;
Caradonna, JP .
CHEMICAL REVIEWS, 1996, 96 (07) :2659-2756
[40]  
Kaufman S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P103